Status:
COMPLETED
The Expression Heparanase in Term and Preterm Placentas
Lead Sponsor:
Hillel Yaffe Medical Center
Conditions:
Preterm Birth
Eligibility:
FEMALE
18-40 years
Brief Summary
Heparanase is an endo-β-glucuronidase that cleaves heparin-sulfate (HS) side chains of heparan sulfate proteoglycans, an integral constituent of the extra cellular matrix (ECM). This study aims to in...
Eligibility Criteria
Inclusion
- Singleton pregnancy
Exclusion
- High-risk patients
- Multiple pregnancy
- Significant maternal illness
- Significant fetal anomaly
Key Trial Info
Start Date :
January 23 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 24 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT03798964
Start Date
January 23 2019
End Date
November 24 2020
Last Update
June 28 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hille Yaffe Medical Center
Hadera, Israel, 38100